Brief: Pharnext Issues Of A Fifth Tranche Of 300 Convertible Bonds
Nov 12 (Reuters) - Pharnext SA PHARN.PA :
* ISSUES OF A FIFTH TRANCHE OF 300 CONVERTIBLE BONDS AND
TOTAL
NUMBER OF OUTSTANDING SHARES AND VOTING RIGHTS
* NOMINAL VALUE OF 10,000 € EACH
* ISSUANCE CONCLUDED WITH GLOBAL TECH OPPORTUNITIES 13
* FUNDS WILL BE USED TO CONTINUE IMPLEMENTATION OF PHASE III
CLINICAL STUDY OF PXT3003 IN CHARCOT-MARIE-TOOTH DISEASE TYPE 1A
AND ONGOING OPEN-LABEL PHASE III EXTENSION STUDY OF PXT3003
Source text for Eikon: ID:nEQ9NQM9Fa
Further company coverage: PHARN.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Pharnext SCA
See all newsBrief: Pharnext Progresses On Charcot-Marie-Tooth Disease Study
Brief: Pharnext Reports Topline Results From Pivotal Phase III Clinical Trial Of PXT3003 In Charcot-Marie-Tooth Disease Type 1A
Brief: Pharnext Receives Offer Valuing Its Drug Candidate For Charcotmarie-Tooth Disease At Over Eur 500 Mln
Brief: Pharnext Appoints Dr Gilbert Wagener As Chief Medical Officer
Brief: Pharnext Reports Significant Progress In Search For Pharmaceutical Partners To Finance Its Development